title: Successful arterial administration therapy of SMANCS for liver metastasis of malignant insulinoma.
authors.affiliation: Third Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Igarashi
authors.forename: T
authors.initials: T
authors.lastname: Ito
authors.forename: K
authors.initials: K
authors.lastname: Ogoshi
authors.forename: T
authors.initials: T
authors.lastname: Kuroiwa
authors.forename: S
authors.initials: S
authors.lastname: Koyanagi
authors.forename: Y
authors.initials: Y
authors.lastname: Arita
authors.forename: T
authors.initials: T
authors.lastname: Sumii
authors.forename: H
authors.initials: H
authors.lastname: Nawata
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006499:Hepatic Artery; D006801:Humans; D007261:Infusions, Intra-Arterial; D007340:Insulinoma / Q000175:diagnosis / Q000188:drug therapy / Q000556:secondary*; D008113:Liver Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000556:secondary*; D008297:Male; D008299:Maleic Anhydrides / Q000008:administration & dosage / Q000627:therapeutic use*; D018761:Multiple Endocrine Neoplasia Type 1 / Q000188:drug therapy*; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D011137:Polystyrenes / Q000008:administration & dosage / Q000627:therapeutic use*; D013157:Splenic Artery; D009353:Zinostatin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D008299:Maleic Anhydrides; D011137:Polystyrenes; C035755:poly(maleic acid-styrene)neocarzinostatin; D009353:Zinostatin